Daily AI-curated articles on clinical trials, FDA updates, and pharmaceutical insights.
The FORWARD clinical trial is evaluating esreboxetine (AXS-14) as a potential fibromyalgia treatment, offering new hope for patients with chronic pain conditions.
Johnson & Johnson positions Icotyde alongside Tremfya as immunology powerhouses, with CEO projecting the new launch could become one of their largest products ever.
FDA issues compliance reminder to medical product companies and researchers about mandatory clinical trial results submission to ClinicalTrials.gov database.
FDA announces voluntary recall of Blaine Labs wound care gel products due to microbial contamination, raising critical safety concerns for clinical research facilities.
Eli Lilly launches multi-location clinical trial for opioid use disorder, targeting patients on buprenorphine therapy with potential treatment innovations.
Charles River Laboratories joins American Heart Association in landmark partnership targeting cardiovascular disease prevention and community health initiatives.
The FDA's approval of Kresladi marks a historic milestone in gene therapy, offering hope for patients with severe Leukocyte Adhesion Deficiency Type I.
FDA alerts clinical researchers to Erbe flexible cryoprobe recall due to rupture risks causing hearing loss, tinnitus, and burns during ENT procedures.
